|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61K 9/06 | |||
| A61K 47/34 | |||
| A61K 8/64 | |||
| A61Q 19/08 | |||
| A61K 8/90 | |||
| A61K 41/00 | |||
| A61K 8/04 | |||
| A61K 47/60 | |||
| A61K 47/64 | |||
| A61K 47/69 |
| (11) | Number of the document | 2257304 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09712268.3 |
| Date of filing the European patent application | 2009-02-11 | |
| (97) | Date of publication of the European application | 2010-12-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/033752 |
| Date | 2009-02-11 |
| (87) | Number | WO 2009/105369 |
| Date | 2009-08-27 |
| (30) | Number | Date | Country code |
| 36139 | 2008-02-22 | US |
| (72) |
HUNT, Terrence, J., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS |
| SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS |